DCC-3009
NCT06630234
Deciphera Pharmaceuticals · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
DCC-3009
Deciphera Pharmaceuticals · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.